
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
EDITORIAL article
Front. Med.
Sec. Dermatology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1573853
This article is part of the Research Topic Advances in Cutaneous Microbial Infections View all 5 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
of immunodeficiency disorders.The gut microbiota, as a vital ecosystem within the human body, has a significant impact on the host's immune system, metabolism, and nervous system. Recent studies have shown that gut microbiota imbalance is closely associated with the occurrence and progression of various diseases, including skin disorders. Meng et al. used bidirectional Mendelian randomization to analyze data from large-scale genome-wide association studies (GWAS) on gut microbiota and herpes zoster (HZ). They identified a potential bidirectional causal relationship between the gut microbiota and HZ. These findings could pave the way for novel therapeutic approaches to address the global burden of HZ.As one of the most common subcutaneous fungal infections, sporotrichosis is transmitted zoonotically through traumatic inoculation of contaminated soil or plants, or through bites and scratches from infected animals, posing a global threat to both humans and animals. Despite its prevalence, treatment options for sporotrichosis remain limited. Li et al. innovatively investigated the antibacterial peptide In-58 for its in vivo and in vitro antifungal activity against Sporothrix globosa. They discovered that this peptide exhibits significant antifungal properties, highlighting its potential as a novel therapeutic agent for sporotrichosis. This study provides a theoretical foundation for the future clinical translation of antimicrobial peptides.Leprosy is a chronic infectious disease caused by Mycobacterium leprae, characterized by its high disabling potential. Data show that Brazil has the second-highest incidence of leprosy in the world, following India, posing a significant challenge to public health. Brito Gonçalves et al. conducted a retrospective analysis of paucibacillary leprosy in Brazil based on research from the past 20 years. Their analysis revealed significant geographical heterogeneity in Brazilian paucibacillary cases, which has profound implications for subgroup analyses. Addressing these disparities through targeted interventions and localized analyses could enhance the effectiveness of leprosy control efforts in the country. Continuous monitoring of case classification and regional trends is essential for adapting strategies to effectively tackle this public health challenge.In conclusion, the studies in this special issue highlight the need for large-scale interdisciplinary research to fully understand the complexities of various infectious skin diseases and their impact on public health. Further in-depth studies on different pathogens are essential to elucidate their mechanisms of infection and host immune responses, providing a foundation for the development of novel diagnostic and therapeutic approaches.
Keywords: pathogenicity, Virulence Factors, host-microbe interaction, antimicrobial resistance, Biofilm formation
Received: 10 Feb 2025; Accepted: 14 Feb 2025.
Copyright: © 2025 Li, Xi and Song. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Fuqiu Li, Second Affiliated Hospital of Jilin University, Changchun, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.